Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.17B | 44.71B | 31.50B | 18.25B | 14.68B | 13.76B |
Gross Profit | 11.51B | 11.39B | 8.51B | 6.02B | 5.14B | 2.60B |
EBITDA | 8.09B | 7.67B | 5.63B | 5.19B | 3.30B | 1.39B |
Net Income | 4.91B | 4.71B | 3.29B | 3.38B | 1.96B | 650.24M |
Balance Sheet | ||||||
Total Assets | 78.42B | 71.25B | 61.21B | 50.67B | 36.33B | 23.63B |
Cash, Cash Equivalents and Short-Term Investments | 9.73B | 13.55B | 12.78B | 9.48B | 6.81B | 2.82B |
Total Debt | 56.31B | 47.95B | 42.76B | 35.40B | 25.75B | 16.21B |
Total Liabilities | 60.80B | 53.12B | 46.00B | 39.25B | 28.99B | 19.28B |
Stockholders Equity | 17.63B | 18.13B | 15.21B | 11.42B | 7.34B | 4.35B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.36B | -4.27B | -4.76B | -6.75B | 856.12M |
Operating Cash Flow | 0.00 | -1.76B | -3.20B | -3.06B | -5.36B | 1.73B |
Investing Cash Flow | 0.00 | -708.53M | -1.40B | -1.48B | -1.17B | -637.30M |
Financing Cash Flow | 0.00 | 3.20B | 7.77B | 6.93B | 10.50B | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥46.60B | 5.30 | 2.46% | 14.08% | 46.84% | ||
75 Outperform | ¥52.40B | 12.49 | 3.67% | 57.21% | 16.38% | ||
72 Outperform | ¥39.35B | 6.08 | 3.99% | 11.98% | 0.42% | ||
71 Outperform | ¥49.04B | 8.16 | 5.10% | 29.46% | 32.52% | ||
70 Outperform | ¥51.80B | 34.63 | 0.29% | 28.02% | 37.68% | ||
64 Neutral | $6.97B | 18.61 | -1.93% | 6.82% | 4.65% | -25.39% |